93154 ⎘
Derivatives of carbamic acids, i.e. compounds containing any of the groups , the nitrogen atom not being part of nitro or nitroso groups; Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
PICOLINAMIDES AS FUNGICIDES
#2CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF
#3Substituted piperazines as disrupters of AB42 oligomer formation
#4SMYD Inhibitors
#5Picolinamides as fungicides
#6Process for the cycloaddition of a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne
#7Method for producing kakeromycin and derivatives thereof
#8CYCLIC PEPTIDES TARGETING ALPHA-4-BETA-7 INTEGRIN
#9SMYD INHIBITORS
#10Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#11Fragment synthesis of substituted cyclic peptides
#12Substituted amines as disrupters of ABETA42 oligomer formation
#13Cyclic peptides targeting alpha-4-beta-7 integrin
#14Enantioselective synthesis of α-quaternary Mannich adducts by palladium-catalyzed allylic alkylation
#15SMYD INHIBITORS
#16Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
#17Picolinamides as fungicides
#18Structure of GII.4 norovirus protease—design of broad-spectrum protease inhibitors
#19Small molecule drugs and related methods for treatment of diseases related to Aβ42 oligomer formation
#20Molecules having pesticidal utility, and intermediates, compositions, and processes related thereto
#21Method for producing kakeromycin and derivatives thereof
#22MOLECULES HAVEING PESTICIDAL UTILIY AND INTERMEDIATES, COMPOSITIONS AND PROCESSES RELATED THERETO
#23Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
#24Alpha-Ketoamide Inhibitors Of Cysteine Proteases
#25Fragment synthesis of substituted cyclic peptides
#26Method for producing kakeromycin and derivatives thereof
#27Method for producing kakeromycin and derivatives thereof
#28Method for producing kakeromycin and derivatives thereof
#29Molecules having pesticidal utility and intermediates, compositions and processes related thereto
#30Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer
#31Organocatalytic asymmetric synthesis of antidepressants
#32Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
#33Antimicrobial compounds
#34Process for the preparation of key intermediates of omarigliptin
#35Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation
#36Intermediate compounds of tamiflu, methods of preparation and uses thereof
#37Process for reduction of alpha-acyloxy sulfide derivatives
#38Method for producing aminobiphenylene
#39Synthesis of a PEG-6 moiety from commercial low-cost chemicals
#40Tricyclic-bis-enone derivatives and methods of use thereof
#41PROCESS FOR MANUFACTURING DISULFONIC ACID COMPOUND, ASYMMETRIC MANNICH CATALST, PROCESS FOR MANUFACTURING BETA-AMINOCARBONYL DERIVATIVE, AND NOVEL DISULFONATE
#42STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES
#43Process for deacetalisation of α aminoacetals
#44METHOD FOR THE PRODUCTION OF CHIRAL AMINOCARBONYL COMPOUNDS
#45Process and intermediates for the preparation of (1,2,5)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
#46TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS
#47Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
#48Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates
#49Amino alcohol derivatives, salts thereof and immunosuppresive agents
#50Compounds to treat alzheimer's disease
#51Optically active 2,5-bisaryl-delta¹ -pyrrolines and their use as pest control agents
#52Bicyclic Compounds Which Inhibit Beta-Secretase Activity and Methods of Use Thereof
#53Compounds and related methods for mutant p53 reactivation
#54Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates for salts thereof
#55Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#56Methods to Treat Alzheimer's Disease
#57Tricyclic-bis-enone derivatives and methods of use thereof
#58Process for production of amines
#59Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
#60Process for the ruthenium-catalysed oxidation of alcohols by means of hypochlorite
#61Compounds to treat alzheimer's disease
#62Compounds to treat Alzheimer's disease
#63Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
#64Compounds for the treatment of Alzheimer's disease
#65Substituted tetracycline compounds
#66Process for producing benzylamine derivative
#67Amino alcohol derivative, addition salt thereof, and immunosuppressant
#68N-protected/N-substituted-beta-amino hydroxy sulfonates
#69Arylalkylcarbamate derivatives and production thereof
#70Synthesis of α-amino-β-alkoxy-carboxylic acid esters
#71Piperizinones as modulators of chemokine receptor activity
#72Compounds and related methods for mutant p53 reactivation
#73Compounds to treat Alzheimer's disease
#74Process for producing β-aminoketone and catalyst therefor
#75Beta-amino ketones for the treatment of pain
#76PPAR compounds
#77Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof